Bridgeway Capital Management, LLC Protagonist Therapeutics, Inc Transaction History

Bridgeway Capital Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	SELL	$6.19 - $18.84 $564,181 - $1.72 Million	-91,144 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$8.98 - $12.96 $271,698 - $392,117	-30,256 Reduced 24.92%	91,144 $1.1 Million
Q1 2019 May 15, 2019	BUY	$6.5 - $13.77 $232,700 - $492,966	35,800 Added 41.82%	121,400 $1.53 Million
Q3 2018 Nov 13, 2018	BUY	$6.82 - $11.26 $238,700 - $394,100	35,000 Added 69.17%	85,600 $881,000
Q2 2018 Aug 14, 2018	BUY	$5.99 - $9.1 $69,484 - $105,560	11,600 Added 29.74%	50,600 $340,000
Q3 2017 Nov 14, 2017	BUY	$10.61 - $17.98 $413,790 - $701,220	39,000	39,000 $689,000

248

56.7M

76.3K

114K

Ticker PTGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,084,100
Market Cap $1.93B
Description
Protagonist Therapeutics, Inc., a biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing rusfertide (PTG-300), an injectable hepcidin mimetic that is in Phase II clinical trials for the treatment of patients with...

Get notified when there are updates to the investment portfolio of Bridgeway Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Bridgeway Capital Management, LLC with notifications on news.